PARIS--(BUSINESS WIRE)--Regulatory News:
Under the liquidity contract entered into between AIR LIQUIDE (Paris:AI) and BNP PARIBAS, the following resources were listed in the liquidity account on December 31, 2023 (trading date):
- 2,100 AIR LIQUIDE shares
- €17,628,230
During the second half of 2023, a total of:
Purchase: 322,104 shares (2,741 transactions) €52,108,335 Sale: 323,054 shares (3,206 transactions) €52,443,177
It is reminded that
As at June 30, 2023, the most recent update, the following resources had been allocated to the liquidity account:
- 4,750 AIR LIQUIDE shares
- €17,001,558
Purchase: 337,852 shares (2,799 transactions) €51,363,492 Sale: 346,653 shares (3,067 transactions) €52,775,425
As at December 31, 2018, the date of implementation of AMF Decision 2018-1 of July 2, 2018, the following resources had been allocated to the liquidity account:
- 9,500 AIR LIQUIDE shares
- €14,986,662
A world leader in gases, technologies and services for Industry and Health, Air Liquide is present in 73 countries with approximately 67,100 employees and serves more than 3.9 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the company’s activities since its creation in 1902.
Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan for 2025, Air Liquide is targeting a global performance, combining financial and extra-financial dimensions. Positioned on new markets, the Group benefits from major assets such as its business model combining resilience and strength, its ability to innovate and its technological expertise. The Group develops solutions contributing to climate and the energy transition—particularly with hydrogen—and takes action to progress in areas of healthcare, digital and high technologies.
Air Liquide’s revenue amounted to more than 29.9 billion euros in 2022. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good and DJSI Europe indexes.
